24.4.2025 15:03:03 CEST | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state

Oslo, Norway, 24 April 2025

The annual general meeting in Thor Medical ASA (the "Company") was held today,
24 April 2025. All items on the agenda were approved in accordance with the
notice. The minutes are attached hereto and are also available on 
https://www.thormedical.no/. 

DISCLOSURE REGULATION

This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.

CONTACTS

Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440, 
brede.ellingseter@thormedical.com



ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn
more, visit www.thormedical.no - http://www.thormedical.no

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18503732/5972/Download%20announce
ment%20as%20PDF.pdf

Thor Medical ASA - Minutes from ordinary general meeting 24 April 2.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18503732/5971/Thor%20Medical%20AS
A%20-%20Minutes%20from%20ordinary%20general%20meeting%2024%20April%202.pdf